Loading clinical trials...
Loading clinical trials...
Chronic liver disease is a major health problem worldwide. Liver fibrosis is a key feature in most chronic liver diseases. When identified early, liver fibrosis may be reversible. Currently, liver bio...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Chinese University of Hong Kong
NCT07417553 · Chronic Hepatitis B-related Liver Fibrosis
NCT07265544 · Liver Neoplasm, HBV Infection, and more
NCT06632444 · Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
NCT06843148 · Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Liver Fibrosis/NASH, and more
NCT07122700 · Metabolic Associated Fatty Liver Disease, Metabolic Associated Steatotic Liver Disease, and more
The Chinese University of Hong Kong, Prince of Wale Hospital
Hong Kong, Shatin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions